Back

Rivaroxaban strategies improve the number of days patients remain out of the hospital and event free: A PIONEER substudy

28 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Stroke prevention Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor C Michael Gibson

Harvard Medical School, Boston (United States of America)

53 More presentations in this session

Presentation thumbnail
Doctor A. Tyminska (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Doctor M. Gupta (Toronto, CA)
Abstract
Presentation thumbnail
Professor H. Bonnemeier (Luebeck, DE)
Abstract Slides
Presentation thumbnail
Ms D. Loikas (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Doctor J. Franchino-Elder (Ridgefield, US)
Abstract

Access the full session

Session thumbnail
Poster session 4 - Stroke prevention

The Event

Event poster

ESC Congress 2017

28 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Clinical impact of switching or continuation of apixaban or rivaroxaban among patients with non-valvular atrial fibrillation
25 August 2023
thumbnail
Congress Presentation
Early DOAC therapy after invasive acute pulmonary embolism therapy: fast track PE?
20 March 2026
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Presentation
Rivaroxaban dosing in patients with atrial fibrillation: results from the RIVER registry- is dosing according to renal function appropriate?
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources